Navigation Links
Vanda Pharmaceuticals Reports First Quarter 2011 Results
Date:5/5/2011

utable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this release is provided only as of the date of this release, and Vanda undertakes no obligation, and specifically declines any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

VANDA PHARMACEUTICALS INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)Three Months EndedMarch 31,March 31,(In thousands, except for per share amounts)

20112010Revenues:Licensing agreement

$

6,606$

6,606Royalty revenue8952,067Product sales-3,748Total revenues7,50112,421Operating expenses:Cost of sales - product-1,375Research and development4,2672,041General and administrative2,8582,489Intangible asset amortization369369Total operating expenses7,4946,274Income from operations76,147Other income:Interest income13547Total other income13547Income before income tax provision1426,194Tax provision 65,665Net income

$

136$

529Net income per share:Basic and diluted

$

0.00$

0.02Shares used in calculation of net income per share:Basic 28,101,41827,704,418Diluted28,936,83528,318,754VANDA PHARMACEUTICALS INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)(In thousands)

March 31, 2011December 31, 2010ASSETSCurrent assets:Cash and cash equivalents

$

52,520$

42,559Marketable securities142,035155,478Accounts receivable895511Prepaid expenses, deposits and other current assets1,6191,843Deferred tax, current 182182Total current assets197,251200,573Property and equipment, net860937Intangible asset, net9,1539,522Deferred tax, non-current 1,6391,639Restricted cash430430Total assets

$<
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
2. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
3. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results
4. Vanda Pharmaceuticals Reports First Quarter 2009 Results
5. Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting
6. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
7. Vanda Pharmaceuticals Reports Second Quarter 2009 Results
8. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Results
9. Vanda Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 5, 2010
10. Vanda Pharmaceuticals to Announce Fourth Quarter 2010 Financial Results on February 10, 2011
11. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015  Approximately 1% of the population inherits ... chromosomes. These individuals are three times more likely to ... one of the nation,s leading medical journals by researchers ... Photo - http://photos.prnewswire.com/prnh/20150706/230685 ... causes roseola (also known as "sixth disease") and occasional ...
(Date:7/6/2015)... Medical, Inc. ("Viveve") (OTCQB: VIVMF), a company focused on women,s health, ... Officer, and Scott Durbin , Viveve,s Chief Financial Officer, ... , , , DATE:    , , , Thursday, ... , , , 12:15 PM EDT , , ... ,    This ...
(Date:7/3/2015)... (PRWEB) , ... July 03, ... ... company providing industry-leading products for use in applications such as animal waste ... wastewater treatment plants and restaurant kitchen settings, announced today that it will ...
(Date:7/3/2015)... WIEN , July 3, 2015 /PRNewswire/ ... fram till 22 september 2015 på  http://www.openinnovationinscience.at ... Open Innovation in Science" som hålls i ... Enligt en färsk undersökning med internationella forskare ... Gesellschaft (LBG) är hälsovetenskapens två största utmaningar ...
Breaking Biology Technology:Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 2Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 3Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3DryLet to Highlight Benefits of Patented ManureMagic™ at North American Manure Expo in Chambersburg, PA July 14-15, 2015 2Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3
... Calif., Dec. 20 Ardea Biosciences,Inc. (Nasdaq: ... and development of,small-molecule therapeutics for the treatment of ... it has entered into a,securities purchase agreement with ... the private placement of approximately 3.0,million newly issued ...
... Dec. 20 ISTO Technologies, Inc., a privately,held orthobiologic ... Finance Forum in San Francisco, CA from January 7-8, ... will present on,Tuesday, January 8th at 11:00 a.m. Pacific ... St. Information about the OneMedPlace Finance Forum may,be found ...
... -- China Technology,Development Group Corporation (Nasdaq: CTDC, "the ... energy products and solutions focusing on,solar energy business ... step in its strategic plan to focus the ... of solar energy., On December 18, 2007, ...
Cached Biology Technology:Ardea Biosciences Announces $40 Million Private Placement 2Ardea Biosciences Announces $40 Million Private Placement 3CTDC Announces the Disposal of Non-core Business 2
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ... Generation Biometrics Market by Application, Technology, Function & Geography ... offering. The next generation biometrics market is ... CAGR of 17.9% between 2015 and 2020 ... market. Safran SA ( France ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
(Date:6/25/2015)... -- TAKE Solutions Ltd., a global business technology solutions provider, ... and Trademark Office (USPTO) for its "Method for Optimizing ... Accelerators to reduce the time taken to standardize trial ... the accelerators), thus reducing time to market. ... heart of the patented Clinical Data Standardization Process are ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Latin America Biomedical Sensors Market Report 2015-2020 2TAKE Solutions Awarded Patent By USPTO 2
... 2008 -- Scientists were surprised with findings of a recent ... small contained areas actually need broad, landscape level conservation to ... than any other time in human history, the findings of ... Letters provides new insight into how to improve protection ...
... Copenhagen has studied human remains found in two ancient Danish ... a man who appears to be of arabian origin. The ... years ago as they are today and indicate greater mobility ... also suggest that people in the Danish iron age did ...
... known like President Bush and musician Neil Young, but Philadelphian ... has a new species named after him. , Gallagher was ... years before retiring in 2003. "They used to call me ... mail to the staff but also passed along the latest ...
Cached Biology News:New study reveals large scale conservation essential 2New study reveals large scale conservation essential 3New research refutes myth of pure Scandinavian race 2New research refutes myth of pure Scandinavian race 3New catfish species named for museum mail supervisor 2
... mass detection but not structural information ... spectrometer is ideally suited for high ... performance mass analysis. Typical applications ... detection, micro-satellite DNA characterization and polymer ...
Rat Aortic Smooth Muscle Cells (RAOSMC) (>500,000 cells)...
Rat Dermal Fibroblasts (RDF) (>500,000 cells)...
... an ideal small concentrator for the molecular ... removing water and organic solvents from a ... vials and round bottom flasks. Making it ... lab. ,The built-in special runs for working ...
Biology Products: